The American Journal of Surgery
Volume 187, Issue 1 , Pages 69-72 , January 2004

Lymphedema after treatment of breast cancer

  • Cihangir Ozaslan, M.D.

      Affiliations

    • Department of Surgery, Ankara Education and Research Hospital, Ankara, Turkey
  • ,
  • Bekir Kuru, M.D.

      Affiliations

    • Department of Surgery, Ankara Education and Research Hospital, Ankara, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90-532-775-5668; fax: +90-312-345-4979.

Received 13 August 2002 ,Revised 12 December 2002

References 

  1. Fisher B, Redmond C, Fisher ER, et al.  Ten-year results of a randomised clinical trial comparing radical mastectomy and total mastectomy with and without radiation. N Engl J Med. 1985;312:674–681
  2. Cady B. The need to re-examine axillary lymph node dissection in invasive breast cancer. Cancer. 1994;73:505–508
  3. Quiet CA, Ferguson DJ, Weichselbaum RR, et al.  Natural history of node negative breast cancer. A study of 826 patients with long-term follow-up. J Clin Oncol. 1995;13:1144–1151
  4. Walker MJ, Osborne MD, Young DC, et al.  The natural history of breast cancer with more than 10 positive nodes. Am J Surg. 1995;169:575–579
  5. Cady B, Stone M, Wayne J. New therapeutic possibilities in primary invasive breast cancer. Ann Surg. 1993;218:338–349
  6. Baxter N, McCready D, Chapman JA, et al.  Clinical behaviour of untreated axillary nodes after local treatment for primary breast cancer. Ann Surg Oncol. 1996;3:235–240
  7. Overgaard M, Hansen P, Overgaard J, et al.  Postoperative radiotherapy in high risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 1997;337:949–955
  8. Ragaz J, Jackson S, Le N, et al.  Adjuvant radiotherapy and chemotherapy in node positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956–962
  9. Esteva F, Hortobagy GN. Adjuvant systemic therapy for primary breast cancer. Surg Clin North Am. 1999;79:1075–1090
  10. Edwards TL. Prevalence and aetiology of lymphedema after breast cancer treatment in Southern Tasmania. Aust NZ J Surg. 2000;70:412–418
  11. Roses DF, Brooks AD, Harris MN, et al.  Complications of level I and II axillary dissection in the treatment of carcinoma of the breast. Ann Surg. 1999;230:194–201
  12. Mortimer PS, Bates DO, Brassington HD, et al.  The prevalence of arm oedema following treatment for breast cancer. Q J Med. 1996;89:377–380
  13. Passik SD, Newman M, Brennan M, Tunkel R. Predictors of psychological distress, sexual dysfunction and physical functioning among women with upper extremity lymphedema related to breast cancer. Pyschol Oncol. 1995;4:259–263
  14. Tobin MB, Lacy HJ, Meyer L, Mortimer PS. The psychological morbidity of breast cancer-related arm swelling. Cancer. 1993;72:3248–3252
  15. Stewart FW, Treves N. Lymphangiosarcoma in postmastectomy lymphedema. A report of six cases in elephantiasis chirurgica. Cancer. 1948;1:64–81
  16. Ivens D, Hoe AL, Podd TJ, et al.  Assessment of morbidity from complete axillary dissection. Br J Cancer. 1992;66:136–138
  17. Larson D, Weinstein M, Goldberg I, et al.  Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys. 1986;12:1575–1582
  18. Brismar B, Ljungdahl I. Postoperative lymphedema after treatment of breast cancer. Acta Chir Scand. 1983;149:687–689
  19. Schünemann H, Willich N. Lymphödeme nach mammakarzinom. Eine studie über 5868 falle. Dtsh Med Wschr. 1997;122:536–541
  20. Kissin MW, della Rovere GQ, Easton D, Westbury G. Risk of lymphedema following the treatment of breast cancer. Br J Surg. 1986;73:580–584
  21. Segerstrom K, Bjerle P, Graffman S, Nystrom A. Factors that influence the incidence of brachial oedema after treatment of breast cancer. Scand J Plast Reconstr Surg Hand Surg. 1992;26:223–227
  22. Kuehn T, Klauss W, Darsow M, et al.  Long-term morbidity following axillary dissection in breast cancer patients—clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat. 2000;64:275–286
  23. Swedborg I, Wallgren A. The effect of pre- and postmastectomy radiotherapy on the degree of edema, shoulder-joint mobility, and gripping force. Cancer. 1981;47:877–881
  24. Hoe AL, Iven D, Royle GT, Taylor I. Incidence of arm swelling following axillary clearance for breast cancer. Br J Surg. 1992;79:261–262
  25. Mortimer PS. The pathophysiology of lymphedema. Cancer. 1998;83:2798–2802
  26. Pezner RD, Patterson MP, Hill R, et al.  Arm lymphedema in patients treated conservatively for breast cancer (relationship to patient age axillary node dissection technique). Int J Radiat Oncol Biol Phys. 1986;12:2079–2083
  27. Kiel KD, Rademacker AW. Early-stage breast cancer (arm edema after wide excision and breast irradiation). Radiology. 1996;198:279–283
  28. Suneson BL. Clinical incidence of lymphedema in breast cancer patients in Jonkoping County, Sweden. Eur J Cancer Care. 1996;5:1–12
  29. Senofsky GM, Moffat FL, Davis K, et al.  Total axillary lymphadenectomy in the management of breast cancer. Arch Surg. 1991;126:1336–1342
  30. Delouche G, Bachelot F, Premont M, Kurtz JM. Conservation treatment of early breast cancer (long term results and complications). Int J Radiat Oncol Biol Phys. 1987;13:29–34
  31. Tadych K, Donegan WL. Postmastectomy seromas and wound drainage. Surg Gynecol Obstet. 1987;165:483–487

PII: S0002-9610(03)00438-0

doi: 10.1016/j.amjsurg.2002.12.003

The American Journal of Surgery
Volume 187, Issue 1 , Pages 69-72 , January 2004